Biohaven (BHVN) Operating Leases (2021 - 2026)

Biohaven has disclosed Operating Leases across 6 years of filings, most recently posting $38.4 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $38.4 million, up 24.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.4 million (up 24.54% YoY), and the FY2025 annual result was $40.0 million, up 21.89% from the prior year.
• Operating Leases came in at $38.4 million for Q1 2026 at Biohaven, down from $40.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $40.4 million in Q3 2025 to a low of $25.3 million in Q3 2024.
• The 5-year median for Operating Leases is $29.8 million (2023), against an average of $31.1 million.
• Across the five-year window, Operating Leases jumped 845.02% in 2022 and declined 10.51% in 2024, its largest moves.
• Biohaven's Operating Leases stood at $30.6 million in 2022, then retreated by 9.85% to $27.6 million in 2023, then increased by 18.91% to $32.8 million in 2024, then gained by 21.89% to $40.0 million in 2025, then slipped by 3.99% to $38.4 million in 2026.
• The last three Operating Leases figures came in at $38.4 million (Q1 2026), $40.0 million (Q4 2025), and $40.4 million (Q3 2025), per Business Quant data.